Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA Trial
American Journal of Hematology · 2025-12 · 100 (12) · 2436-2441
DOI: 10.1002/ajh.70091 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Hematology, online erschienen am 02.10.2025. Verfasst von Katja Sockel und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Hydrazines, Pyrazoles, Leukemia, Myeloid, Acute, Benzoates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.
- Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.
- Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
- Department of Internal Medicine 3, Klinikum Chemnitz GmbH, Chemnitz, Germany.
- Department of Hematology, University Hospital Essen, Essen, Germany.
- Klinik für Innere Medizin 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nuremberg, Germany.
ORCID-Profile: Katja Sockel, Sven Zukunft, Ruth Seggewiss-Bernhardt
Zitieren
APA
Sockel, K., Röllig, C., Mütherig, A., Crysandt, M., Zukunft, S., Herbst, R., Noppeney, R., Schäfer-Eckardt, K., Kaufmann, M., Oelschlaegel, U., Fiebig, F., Giagounides, A., Götze, K., Scholl, S., Lück, A., Rieger, K., Geer, T., Kiewe, P., Müller-Tidow, C., …, & Platzbecker, U. (2025). Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA Trial. American Journal of Hematology, 100(12), 2436-2441. https://doi.org/10.1002/ajh.70091
Vancouver
Sockel K, Röllig C, Mütherig A, Crysandt M, Zukunft S, Herbst R, et al. Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA Trial. American Journal of Hematology. 2025;100(12):2436-2441. doi:10.1002/ajh.70091
BibTeX
@article{Sockel2025,
author = {Sockel, Katja and Röllig, Christoph and Mütherig, Anke and Crysandt, Martina and Zukunft, Sven and Herbst, Regina and Noppeney, Richard and Schäfer-Eckardt, Kerstin and Kaufmann, Martin and Oelschlaegel, Uta and Fiebig, Frank and Giagounides, Aristoteles and Götze, Katharina and Scholl, Sebastian and Lück, Andreas and Rieger, Kathrin and Geer, Thomas and Kiewe, Philipp and Müller-Tidow, Carsten and Serve, Hubert and Baldus, Claudia D and Kaiser, Ulrich and Mahlmann, Stefan and Schmidt, Burkhard and Parmentier, Stefani and Illmer, Thomas and Seggewiss-Bernhardt, Ruth and Kiani, Alexander and Linde, Hartmut and Dürk, Heinz and Kramer, Michael and Kunadt, Desiree and Schmidt-Brücken, Katharina and Balaian, Ekaterina and Trautmann-Grill, Karolin and Ruhnke, Leo and Middeke, Jan Moritz and von Bonin, Malte and Ehninger, Gerhard and Thiede, Christian and Bornhäuser, Martin and Schetelig, Johannes and Platzbecker, Uwe},
title = {Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA Trial},
journal = {American Journal of Hematology},
year = {2025},
volume = {100},
number = {12},
pages = {2436--2441},
doi = {10.1002/ajh.70091}
}
EUVIMED